HCPCS Level IIdrugActive
J3402
Inj. remestemcel-l-rknd/ td
BETOS: O1E
Effective: 2025-10-01
Description
Injection, remestemcel-l-rknd, per therapeutic dose
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Ryoncil
Manufacturer
Mesoblast, Inc.
HCPCS Dosage
Per Therapeutic Dose
Billing Units
1.0000
8
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.